| COVID-19 |
1 |
1 |
| Cancer |
0 |
0.99 |
| COVID-19 Vaccine |
0 |
0.98 |
| Biologic Therapy |
0 |
0.8 |
| Metastasis |
0 |
0.7 |
| Vaccines |
0 |
0.97 |
| HIV Infection |
0 |
0.25 |
| Immunization |
0 |
0.18 |
| Stem Cell Research and Therapy |
0 |
0.14 |
| Transplantation |
0 |
0.14 |
| Organ Transplantation |
0 |
0.13 |
| Anaphylaxis |
0 |
0.11 |
| Graft Versus Host Disease and Transplant Complications |
0 |
0.11 |
| Immunocompromise |
0 |
0.09 |
| Immunosuppressive Therapy |
0 |
0.09 |
| Graft Versus Host Disease |
0 |
0.06 |
| Antigens |
0 |
0.04 |
| Autoimmune Disease |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Graft |
0 |
0.04 |
| Immunotherapy |
0 |
0.04 |
| Outpatient Clinic |
0 |
0.04 |
| Radiation Therapy |
0 |
0.04 |
| Receptors |
0 |
0.04 |
| Remission |
0 |
0.04 |
| Surgery |
0 |
0.04 |
| T-Lymphocyte |
0 |
0.04 |
| Tumor |
0 |
0.04 |
| Health Care Reform |
0 |
0.03 |